# Circadian Phase Adjustment and Improvement of Metabolic Control in Night Shift Workers

> **NCT02108353** · PHASE3 · COMPLETED · sponsor: **Universitätsklinikum Hamburg-Eppendorf** · enrollment: 46 (actual)

## Conditions studied

- Sleep Disorders, Circadian Rhythm

## Interventions

- **DRUG:** Melatonin 2mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02108353
- **Lead sponsor:** Universitätsklinikum Hamburg-Eppendorf
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2017-03-29
- **Final completion:** 2017-03-29
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2017-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02108353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02108353, "Circadian Phase Adjustment and Improvement of Metabolic Control in Night Shift Workers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02108353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*